The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Therapeutic Cancer Vaccines: Current Status and Moving Forward
Open accessAbstract
Concurrent with U.S. Food and Drug Administration (FDA) approval of the first therapeutic cancer vaccine, a wide spectrum of other cancer vaccine platforms that target a diverse range of tumor-associated antigens is currently being evaluated in randomized phase II and phase III trials. The profound influence of the tumor microenvironment and other immunosuppressive entities, however, can limit the effectiveness of these vaccines. Numerous strategies are currently being evaluated both preclinically and clinically to counteract these immunosuppressive entities, including the combined use of vaccines with immune checkpoint inhibitors, certain chemotherapeutics, small-molecule targeted therapies, and radiation. The potential influence of the appropriate patient population and clinical trial endpoint in vaccine therapy studies is discussed, as well as the potential importance of biomarkers in future directions of this field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001294 · Cited by 5,572
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908492 · Cited by 3,034
Brahmer, J. R., Drake, C. G., Wollner, I., Powderly, J. D., Picus, J., Sharfman, W. H., Stankevich, E., Pons, A., Salay, T. M., McMiller, T. L., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.7609 · Cited by 2,961
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051424 · Cited by 2,135
Denkert, C., Loibl, S., Noske, A., Roller, M., Müller, B. M., Komor, M., Budczies, J., Darb-Esfahani, S., Kronenwett, R., Hanusch, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.7370 · Cited by 1,762
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Carmeliet, P., & Jain, R. K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3455 · Cited by 1,675
Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo
Schluns, K. S., Kieper, W. C., Jameson, S. C., & Lefrançois, L. (2000) · Nature Immunology · doi:10.1038/80868 · Cited by 1,618
mTOR regulates memory CD8 T-cell differentiation
Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., & Ahmed, R. (2009) · Nature · doi:10.1038/nature08155 · Cited by 1,575
Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal Metastases
Choti, M. A., Sitzmann, J. V., Tiburi, M. F., Sumetchotimetha, W., Rangsin, R., Schulick, R. D., Lillemoe, K. D., Yeo, C. J., & Cameron, J. L. (2002) · Annals of Surgery · doi:10.1097/00000658-200206000-00002 · Cited by 1,454
Mucins in cancer: function, prognosis and therapy
Kufe, D. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2761 · Cited by 1,396
Cheever, M. A., Allison, J. P., Ferris, A. S., Finn, O. J., Hastings, B. M., Hecht, T. T., Mellman, I., Prindiville, S. A., Viner, J. L., Weiner, L. M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0737 · Cited by 1,388
Horder, & Harnett, W. L. (1941) · BMJ · doi:10.1136/bmj.1.4186.493 · Cited by 1,314
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Nagaraj, S., Gupta, K., Pisarev, V., Kinarsky, L., Sherman, S., Kang, L., Herber, D. L., Schneck, J., & Gabrilovich, D. I. (2007) · Nature Medicine · doi:10.1038/nm1609 · Cited by 1,174
Immunogenic death of colon cancer cells treated with oxaliplatin
Tesniere, A., Schlemmer, F., Boige, V, Kepp, O., Martins, I., Ghiringhelli, F., Aymeric, L., Michaud, M., Apetoh, L., Barault, L., et al. (2010) · Oncogene · doi:10.1038/onc.2009.356 · Cited by 1,173
Pawlik, T. M., Scoggins, C. R., Zorzi, D., Abdalla, E. K., Andres, A., Eng, C., Curley, S. A., Loyer, E. M., Muratore, A., Mentha, G., et al. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000160703.75808.7d · Cited by 1,101
van Elsas, A., Hurwitz, A. A., & Allison, J. P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.3.355 · Cited by 1,020
Hodi, F. S., Mihm, M. C., Soiffer, R. J., Haluska, F. G., Butler, M., Seiden, M. V., Davis, T., Henry-Spires, R., MacRae, S., Willman, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0830997100 · Cited by 1,006
Kantoff, P. W., Schuetz, T. J., Blumenstein, B. A., Glode, L. M., Bilhartz, D. L., Wyand, M., Manson, K., Panicali, D. L., Laus, R., Schlom, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.0597 · Cited by 982
Self-citationIn Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
Pagès, F., Kirilovsky, A., Mlecnik, B., Asslaber, M., Tosolini, M., Bindea, G., Lagorce, C., Wind, P., Marliot, F., Bruneval, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6147 · Cited by 954
gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
Schwartzentruber, D. J., Lawson, D. H., Richards, J. M., Conry, R. M., Miller, D. M., Treisman, J., Gailani, F., Riley, L., Conlon, K., Pockaj, B., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012863 · Cited by 911
The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4
Mata-Haro, V., Cekic, C., Martin, M., Chilton, P. M., Casella, C. R., & Mitchell, T. C. (2007) · Science · doi:10.1126/science.1138963 · Cited by 896
Ko, J. S., Zea, A. H., Rini, B. I., Ireland, J. L., Elson, P., Cohen, P., Golshayan, A., Rayman, P. A., Wood, L., Garcia, J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1332 · Cited by 862
Matsuzaki, J., Gnjatic, S., Mhawech-Fauceglia, P., Beck, A., Miller, A., Tsuji, T., Eppolito, C., Qian, F., Lele, S., Shrikant, P., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003345107 · Cited by 859
Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
Condamine, T., & Gabrilovich, D. I. (2011) · Trends in Immunology · doi:10.1016/j.it.2010.10.002 · Cited by 845
Higano, C. S., Schellhammer, P. F., Small, E. J., Burch, P. A., Nemunaitis, J., Yuh, L., Provost, N., & Frohlich, M. W. (2009) · Cancer · doi:10.1002/cncr.24429 · Cited by 810
Banchereau, J., Palucka, A. K., Dhodapkar, M. V., Burkeholder, S. B., Taquet, N., Rolland, A., Taquet, S., Coquery, S., Wittkowski, K. M., Bhardwaj, N., et al. (2001) · PubMed · Cited by 806
Tan, J. T., Ernst, B., Kieper, W. C., LeRoy, E., Sprent, J., & Surh, C. D. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020066 · Cited by 786
Boni, A., Cogdill, A. P., Dang, P., Udayakumar, D., Njauw, C.-N. J., Sloss, C. M., Ferrone, C. R., Flaherty, K. T., Lawrence, D. P., Fisher, D. E., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0118 · Cited by 742
Gastrosplenic Fistula From Hodgkin's Lymphoma
Seib, C. D., Rocha, F. G., Hwang, D. G., & Shoji, B. T. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.7695 · Cited by 735
Corral, L. G., Haslett, P. A. J., Muller, G. W., Chen, R., Wong, L. M., Ocampo, C. J., Patterson, R. T., Stirling, D., & Kaplan, G. (1999) · PubMed · Cited by 729
A NEW PROGNOSTIC CLASSIFICATION OF RECTAL CANCER
Jass, J. R., Love, S. B., & Northover, J. M. A. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90552-6 · Cited by 701
Interleukin 15 Is Required for Proliferative Renewal of Virus-specific Memory CD8 T Cells
Becker, T. C., Wherry, E. J., Boone, D., Murali-Krishna, K., Antia, R., Ma, A., & Ahmed, R. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020369 · Cited by 683
Prognostic Model for Predicting Survival in Men With Hormone-Refractory Metastatic Prostate Cancer
Halabi, S., Small, E. J., Kantoff, P. W., Kattan, M. W., Kaplan, E. B., Dawson, N. A., Levine, E. G., Blumenstein, B. A., & Vogelzang, N. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.100 · Cited by 674
Corral, L. G., Haslett, P. A. J., Muller, G. W., Chen, R., Wong, L.-M., Ocampo, C. J., Patterson, R. T., Stirling, D. I., & Kaplan, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.380 · Cited by 656
Cancer vaccines: between the idea and the reality
Finn, O. J. (2003) · Nature Reviews Immunology · doi:10.1038/nri1150 · Cited by 636
Harnessing the biology of IL-7 for therapeutic application
Mackall, C. L., Fry, T. J., & Gress, R. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2970 · Cited by 571
Okada, H., Kalinski, P., Ueda, R., Hoji, A., Kohanbash, G., Donegan, T. E., Mintz, A. H., Engh, J. A., Bartlett, D. L., Brown, C. K., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.7744 · Cited by 567
The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance
Fry, T. J., & Mackall, C. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.6571 · Cited by 563
Improved Endpoints for Cancer Immunotherapy Trials
Hoos, A., Eggermont, A. M. M., Janetzki, S., Hodi, F. S., Ibrahim, R., Anderson, A., Humphrey, R., Blumenstein, B., Old, L., & Wolchok, J. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq310 · Cited by 518
House, M. G., Ito, H., Gönen, M., Fong, Y., Allen, P. J., DeMatteo, R. P., Brennan, M. F., Blumgart, L. H., Jarnagin, W. R., & D'Angelica, M. I. (2010) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2009.12.040 · Cited by 517
Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.
Moss, B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11341 · Cited by 515
Kodumudi, K. N., Woan, K., Gilvary, D. L., Sahakian, E., Wei, S., & Djeu, J. Y. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0733 · Cited by 500
Finke, J. H., Rini, B., Ireland, J., Rayman, P., Richmond, A., Golshayan, A., Wood, L., Elson, P., Garcia, J., Dreicer, R., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5212 · Cited by 492
Jacoby, R. F., Seibert, K., Cole, C. E., Kelloff, G. J., & Lubet, R. A. (2000) · PubMed · Cited by 478
Sportès, C., Hakim, F. T., Memon, S. A., Zhang, H., Chua, K. S., Brown, M. R., Fleisher, T. A., Krumlauf, M. C., Babb, R. R., Chow, C. K., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071681 · Cited by 476
FUKUMURA, D., DUDA, D. G., MUNN, L. L., & JAIN, R. K. (2010) · Microcirculation · doi:10.1111/j.1549-8719.2010.00029.x · Cited by 451
Antonia, S. J., Mirza, N., Fricke, I., Chiappori, A., Thompson, P., Williams, N., Bepler, G., Simon, G., Janssen, W., Lee, J.-H., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2013 · Cited by 444
Immune resistance orchestrated by the tumor microenvironment
Gajewski, T. F., Meng, Y., Blank, C., Brown, I., Kacha, A., Kline, J., & Harlin, H. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00442.x · Cited by 437
Bogdahn, U., Hau, P., Stockhammer, G., Venkataramana, N. K., Mahapatra, A. K., Suri, A., Balasubramaniam, A., Nair, S., Oliushine, V., Parfenov, V., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/noq142 · Cited by 433
Randomized Phase IIB Trial of BLP25 Liposome Vaccine in Stage IIIB and IV Non–Small-Cell Lung Cancer
Butts, C., Murray, N., Maksymiuk, A., Goss, G., Marshall, E., Soulières, D., Cormier, Y., Ellis, P., Price, A., Sawhney, R., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.13.011 · Cited by 428
RECIST revisited: A review of validation studies on tumour assessment
Therasse, P., Eisenhauer, E. A., & Verweij, J. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.026 · Cited by 422
Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
Nagaraj, S., Schrum, A. G., Cho, H.-I., Celis, E., & Gabrilovich, D. I. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902661 · Cited by 414
High antigen levels are the cause of T cell exhaustion during chronic viral infection
Mueller, S. N., & Ahmed, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809818106 · Cited by 406
Eric, L., Yeo, C. J., Lillemoe, K. D., Biedrzycki, B., Kobrin, B., Herman, J., Sugar, E., Piantadosi, S., Cameron, J. L., Solt, S., et al. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e3181fd271c · Cited by 403
Fernando, R. I., Castillo, M. D., Litzinger, M., Hamilton, D. H., & Palena, C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0156 · Cited by 400
Burton, J. D., Bamford, R. N., Peters, C., Grant, A. J., Kurys, G., Goldman, C. K., Brennan, J., Roessler, E., & Waldmann, T. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4935 · Cited by 397
T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer
Mercader, M., Bodner, B. K., Moser, M. T., Kwon, P. S., Park, E. S. Y., Manecke, R. G., Ellis, T. M., Wojcik, E. M., Yang, D., Flanigan, R. C., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251140998 · Cited by 393
Cham, C. M., Driessens, G., O'Keefe, J. P., & Gajewski, T. F. (2008) · European Journal of Immunology · doi:10.1002/eji.200838289 · Cited by 388
Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
Zitvogel, L., Kepp, O., Senovilla, L., Menger, L., Chaput, N., & Kroemer, G. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2891 · Cited by 387
Interleukin-15 biology and its therapeutic implications in cancer
Steel, J. C., Waldmann, T. A., & Morris, J. C. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.09.004 · Cited by 361
Marshall, J. L., Hoyer, R. J., Toomey, M. A., Faraguna, K., Chang, P., Richmond, E., Pedicano, J. E., Gehan, E., Peck, R. A., Arlen, P., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.23.3964 · Cited by 357
Self-citationJochems, C., & Schlom, J. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011007 · Cited by 353
Self-citationCesana, G. C., DeRaffele, G., Cohen, S., Moroziewicz, D., Mitcham, J., Stoutenburg, J., Cheung, K., Hesdorffer, C., Kim-Schulze, S., & Kaufman, H. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.6830 · Cited by 349
Laheru, D., Lutz, E., Burke, J., Biedrzycki, B., Solt, S., Onners, B., Tartakovsky, I., Nemunaitis, J., Le, D., Sugar, E., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0371 · Cited by 346
Twelve immunotherapy drugs that could cure cancers
‘Mac’ Cheever, M. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00604.x · Cited by 341
Genome-wide analysis of cancer/testis gene expression
Hofmann, O., Caballero, O. L., Stevenson, B. J., Chen, Y.-T., Cohen, T., Chua, R., Maher, C. A., Panji, S., Schaefer, U., Kruger, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810777105 · Cited by 336
Coordination of Intratumoral Immune Reaction and Human Colorectal Cancer Recurrence
Camus, M., Tosolini, M., Mlecnik, B., Pagès, F., Kirilovsky, A., Berger, A., Costes, A., Bindea, G., Charoentong, P., Bruneval, P., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2654 · Cited by 306
Weber, J. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.09.005 · Cited by 306
Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer
Disis, M. L., Wallace, D. R., Gooley, T. A., Dang, Y., Slota, M., Lu, H., Coveler, A. L., Childs, J. S., Higgins, D. M., Fintak, P. A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.6789 · Cited by 300
A triad of costimulatory molecules synergize to amplify T-cell activation.
Hodge, J. W., Sabzevari, H., Yafal, A. G., Gritz, L. R., Lorenz, M. G., & Schlom, J. (1999) · PubMed · Cited by 297
Self-citationFeatures of responding T cells in cancer and chronic infection
Kim, P. S., & Ahmed, R. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.02.005 · Cited by 297
Gulley, J. L., Arlen, P. M., Madan, R. A., Tsang, K.-Y., Pazdur, M. P., Skarupa, L., Jones, J. L., Poole, D. J., Higgins, J. P., Hodge, J. W., et al. (2010) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-009-0782-8 · Cited by 297
Self-citationMarshall, J. L., Gulley, J. L., Arlen, P. M., Beetham, P. K., Tsang, K.-Y., Slack, R., Hodge, J. W., Doren, S., Grosenbach, D. W., Hwang, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.206 · Cited by 297
Self-citationMolecular determinants of immunogenic cell death elicited by anticancer chemotherapy
Kepp, O., Galluzzi, L., Martins, I., Schlemmer, F., Adjemian, S., Michaud, M., Sukkurwala, A. Q., Menger, L., Zitvogel, L., & Kroemer, G. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9273-4 · Cited by 297
Arlen, P. M., Gulley, J. L., Parker, C., Skarupa, L., Pazdur, M., Panicali, D., Beetham, P., Tsang, K. Y., Grosenbach, D. W., Feldman, J., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2059 · Cited by 287
Self-citationInterleukin-7: master regulator of peripheral T-cell homeostasis?
Fry, T. J., & Mackall, C. L. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02028-2 · Cited by 287
Interleukin 15 Skews Monocyte Differentiation into Dendritic Cells with Features of Langerhans Cells
Mohamadzadeh, M., Bérard, F., Essert, G., Chalouni, C. M., Pulendran, B., Davoust, J. M., Bridges, G. E., Palucka, K., & Banchereau, J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.7.1013 · Cited by 274
Role of Dendritic Cell Targeting in Venezuelan Equine Encephalitis Virus Pathogenesis
MacDonald, G. H., & Johnston, R. E. (2000) · Journal of Virology · doi:10.1128/jvi.74.2.914-922.2000 · Cited by 265
Immune Suppression in the Tumor Microenvironment
Gajewski, T. F., Meng, Y., & Harlin, H. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000199193.29048.56 · Cited by 265
Ohtani, M., Nagai, S., Kondo, S., Mizuno, S., Nakamura, K., Tanabe, M., Takeuchi, T., Matsuda, S., & Koyasu, S. (2008) · Blood · doi:10.1182/blood-2008-02-137430 · Cited by 265
Fernando, R. I., Litzinger, M., Trono, P., Hamilton, D. H., Schlom, J., & Palena, C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38379 · Cited by 260
Self-citationHoover, H. C., Brandhorst, J. S., Peters, L. C., Surdyke, M. G., Takeshita, Y., Madariaga, J., Muenz, L. R., & Hanna, M. G. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.390 · Cited by 259
Cytokines and Immune Response in the Tumor Microenvironment
Mocellin, S., Wang, E., & Marincola, F. M. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200109000-00002 · Cited by 259
Butterfield, L. H., Ribas, A., Dissette, V. B., Amarnani, S. N., Vu, H. T., Oseguera, D. K., Wang, H.-J., Elashoff, R. M., McBride, W. H., Mukherji, B., et al. (2003) · PubMed · Cited by 255
Shusterman, S., London, W. B., Gillies, S. D., Hank, J. A., Voss, S. D., Seeger, R. C., Reynolds, C. P., Kimball, J., Albertini, M. R., Wagner, B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.8861 · Cited by 248
Stein, W. D., Gulley, J. L., Schlom, J., Madan, R. A., Dahut, W., Figg, W. D., Ning, Y.-M., Arlen, P. M., Price, D., Bates, S. E., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1762 · Cited by 247
Self-citationAvigan, D., Vasir, B., Gong, J., Borges, V., Wu, Z., Uhl, L., Atkins, M., Mier, J., McDermott, D., Smith, T., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0347 · Cited by 246
Schuster, S. J., Neelapu, S. S., Gause, B. L., Janik, J. E., Muggia, F. M., Gockerman, J. P., Winter, J. N., Flowers, C. R., Nikcevich, D. A., Sotomayor, E. M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.3005 · Cited by 245
Emens, L. A., Asquith, J. M., Leatherman, J. M., Kobrin, B. J., Petrik, S., Laiko, M., Levi, J., Daphtary, M. M., Biedrzycki, B., Wolff, A. C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.3494 · Cited by 236
Garnett, C. T., Schlom, J., & Hodge, J. W. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4025 · Cited by 232
Self-citationFailure at the Effector Phase: Immune Barriers at the Level of the Melanoma Tumor Microenvironment
Gajewski, T. F. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0892 · Cited by 230
Gulley, J. L., Arlen, P. M., Tsang, K.-Y., Yokokawa, J., Palena, C., Poole, D. J., Remondo, C., Cereda, V., Jones, J. L., Pazdur, M. P., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0126 · Cited by 228
Self-citationSportès, C., Babb, R. R., Krumlauf, M. C., Hakim, F. T., Steinberg, S. M., Chow, C. K., Brown, M. R., Fleisher, T. A., Noel, P., Maric, I., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1303 · Cited by 227
Greiner, J. W., Hand, P. H., Noguchi, P. D., Fisher, P. B., Pestka, S., & Schlom, J. (1984) · PubMed · Cited by 221
Self-citationSanda, M. G., Smith, D. C., Charles, L. G., Hwang, C., Pienta, K. J., Schlom, J., Milenic, D., Panicali, D., & Montie, J. E. (1999) · Urology · doi:10.1016/s0090-4295(98)00539-1 · Cited by 201
Self-citationBueno, L., de Alwis, D. P., Pitou, C., Yingling, J., Lahn, M., Glatt, S., & Trocóniz, I. F. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2007.10.008 · Cited by 201
Interleukin-2 receptor signaling in regulatory T cell development and homeostasis
Burchill, M. A., Yang, J., Vang, K. B., & Farrar, M. A. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.08.005 · Cited by 199
Spisek, R., Kukreja, A., Chen, L.-C., Matthews, P., Mazumder, A., Vesole, D., Jagannath, S., Zebroski, H. A., Simpson, A. J. G., Ritter, G., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062387 · Cited by 199
Li, B., VanRoey, M., Wang, C., Chen, T.-H. T., Korman, A., & Jooss, K. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1825 · Cited by 191
Litzinger, M. T., Fernando, R., Curiel, T. J., Grosenbach, D. W., Schlom, J., & Palena, C. (2007) · Blood · doi:10.1182/blood-2007-06-094615 · Cited by 188
Self-citationOh, S., Berzofsky, J. A., Burke, D. S., Waldmann, T. A., & Perera, L. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630592100 · Cited by 187
Vaccine-Induced CD4+ T Cell Responses to MAGE-3 Protein in Lung Cancer Patients
Atanackovic, D., Altorki, N. K., Stockert, E., Williamson, B., Jungbluth, A. A., Ritter, E., Santiago, D., Ferrara, C. A., Matsuo, M., Selvakumar, A., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3289 · Cited by 184
Dependence on the MUC1-C Oncoprotein in Non–Small Cell Lung Cancer Cells
Raina, D., Kosugi, M., Ahmad, R., Panchamoorthy, G., Rajabi, H., Alam, M., Shimamura, T., Shapiro, G. I., Supko, J., Kharbanda, S., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-1050 · Cited by 178
Seromic profiling of ovarian and pancreatic cancer
Gnjatic, S., Ritter, E., Büchler, M. W., Giese, N. A., Brors, B., Frei, C., Murray, A., Halama, N., Zörnig, I., Chen, Y.-T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914213107 · Cited by 176
Recombinant Interferon Enhances Monoclonal Antibody-Targeting of Carcinoma Lesions in Vivo
Greiner, J. W., Guadagni, F., Noguchi, P., Pestka, S., Colcher, D., Fisher, P. B., & Schlom, J. (1987) · Science · doi:10.1126/science.3580039 · Cited by 174
Self-citationvon Mehren, M., Arlen, P. M., Gulley, J. L., Rogatko, A., Cooper, H. S., Meropol, N. J., Alpaugh, R. K., Davey, M., McLaughlin, S. B., Beard, M., et al. (2001) · PubMed · Cited by 170
Self-citationPalena, C., Polev, D. E., Tsang, K. Y., Fernando, R. I., Litzinger, M., Krukovskaya, L. L., Baranova, A. V., Kozlov, A. P., & Schlom, J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2353 · Cited by 166
Self-citationGribben, J. G., Ryan, D. P., Boyajian, R., Urban, R. G., Hedley, M. L., Beach, K., Nealon, P., Matulonis, U., Campos, S., Gilligan, T. D., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2111 · Cited by 165
Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice
Pfannenstiel, L. W., Lam, S. S. K., Emens, L. A., Jaffee, E. M., & Armstrong, T. D. (2010) · Cellular Immunology · doi:10.1016/j.cellimm.2010.03.001 · Cited by 159
HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection
Kemp, T. J., Hildesheim, A., Safaeian, M., Dauner, J. G., Pan, Y., Porras, C., Schiller, J. T., Lowy, D. R., Herrero, R., & Pinto, L. A. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.01.001 · Cited by 158
Transient T cell depletion causes regression of melanoma metastases
Rasku, M. A., Clem, A. L., Telang, S., Taft, B., Gettings, K., Gragg, H., Cramer, D., Lear, S. C., McMasters, K. M., Miller, D. M., et al. (2008) · Journal of Translational Medicine · doi:10.1186/1479-5876-6-12 · Cited by 158
von Mehren, M., Arlen, P. M., Tsang, K. Y., Rogatko, A., Meropol, N. J., Cooper, H. S., Davey, M. P., McLaughlin, S. B., Schlom, J., & Weiner, L. M. (2000) · PubMed · Cited by 156
Self-citationYokokawa, J., Cereda, V., Remondo, C., Gulley, J. L., Arlen, P. M., Schlom, J., & Tsang, K. Y. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2056 · Cited by 155
Self-citationVansteenkiste, J., Zielinski, M., Linder, A., Dahabre, J., Esteban, E., Malinowski, W., Jassem, J., Passlick, B., Lehmann, F. F., & Brichard, V. G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.7554 · Cited by 151
Clinical Benefit Associated With Idiotypic Vaccination in Patients With Follicular Lymphoma
Inogés, S., Rodrı́guez-Calvillo, M., Zabalegui, N., de Cerio, A. L.-D., Villanueva, H., Soria, E., Suárez, L., Rodríguez‐Caballero, A., Pastor, F., García‐Muñoz, R., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj358 · Cited by 150
Madan, R. A., Gulley, J. L., Schlom, J., Steinberg, S. M., Liewehr, D. J., Dahut, W. L., & Arlen, P. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5048 · Cited by 150
Self-citationNemunaitis, J., Nemunaitis, M., Senzer, N., Snitz, P., Bedell, C., Kumar, P., Pappen, B., Maples, P. B., Shawler, D., & Fakhrai, H. (2009) · Cancer Gene Therapy · doi:10.1038/cgt.2009.15 · Cited by 147
Freedman, A. S., Neelapu, S. S., Nichols, C. R., Robertson, M. J., Djulbegović, B., Winter, J. N., Bender, J. F., Gold, D. P., Ghalie, R., Stewart, M. E., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.8903 · Cited by 138
Multiple Costimulatory Modalities Enhance CTL Avidity
Hodge, J. W., Chakraborty, M., Kudo‐Saito, C., Garnett‐Benson, C., & Schlom, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.5994 · Cited by 138
Self-citationMadan, R. A., Gulley, J. L., Fojo, T., & Dahut, W. L. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-0129 · Cited by 138
Williams, K. M., & Gress, R. E. (2008) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2008.06.003 · Cited by 137
Synergy of vaccine strategies to amplify antigen-specific immune responses and antitumor effects.
Grosenbach, D. W., Barrientos, J. C., Schlom, J., & Hodge, J. W. (2001) · PubMed · Cited by 132
Self-citationFarsaci, B., Higgins, J. P., & Hodge, J. W. (2011) · International Journal of Cancer · doi:10.1002/ijc.26219 · Cited by 127
Immunologic biomarkers as correlates of clinical response to cancer immunotherapy
Disis, M. L. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0960-8 · Cited by 120
Arru, M., Aldrighetti, L. A., Castoldi, R., Palo, S. D., Orsenigo, E., Stella, M., Pulitanò, C., Gavazzi, F., Ferla, G., Carlo, V. D., et al. (2007) · World Journal of Surgery · doi:10.1007/s00268-007-9285-y · Cited by 119
Selective Induction of High Avidity CTL by Altering the Balance of Signals from APC
Oh, S., Hodge, J. W., Ahlers, J. D., Burke, D. S., Schlom, J., & Berzofsky, J. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2523 · Cited by 116
Self-citationDeterminant spreading and tumor responses after peptide-based cancer immunotherapy
Ribas, A., Timmerman, J. M., Butterfield, L. H., & Economou, J. S. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(02)00029-7 · Cited by 114
Vezys, V., Penaloza‐MacMaster, P., Barber, D. L., Ha, S., Konieczny, B. T., Freeman, G. J., Mittler, R. S., & Ahmed, R. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100077 · Cited by 109
Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers
Butterfield, L. H., Palucka, A. K., Britten, C. M., Dhodapkar, M. V., Håkansson, L., Janetzki, S., Kawakami, Y., Kleen, T. O., Lee, P. P., Maccalli, C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2234 · Cited by 108
Intravesical Immunotherapy of Superficial Bladder Cancer with Chitosan/Interleukin-12
Zaharoff, D. A., Hoffman, B. S., Hooper, H. B., Benjamin, C. J., Khurana, K. K., Hance, K. W., Rogers, C. J., Pinto, P. A., Schlom, J., & Greiner, J. W. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1114 · Cited by 107
Self-citationLuiten, R. M., Taanman-Kueter, E. W., Mooi, W. J., Gallee, M. P. W., Rankin, E. M., Gerritsen, W. R., Clift, S., Nooijen, W. J., Weder, P., van de Kasteele, W., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.6816 · Cited by 107
Lechleider, R. J., Arlen, P. M., Tsang, K.-Y., Steinberg, S. M., Yokokawa, J., Cereda, V., Camphausen, K. A., Schlom, J., Dahut, W. L., & Gulley, J. L. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5162 · Cited by 106
Self-citationVaccine therapy of established tumors in the absence of autoimmunity.
Hodge, J. W., Grosenbach, D. W., Aarts, W. M., Poole, D. J., & Schlom, J. (2003) · PubMed · Cited by 103
Self-citationSosman, J. A., Carrillo, C., Urba, W. J., Flaherty, L. E., Atkins, M. B., Clark, J. I., Dutcher, J., Margolin, K. A., Mier, J. W., Gollob, J., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.3165 · Cited by 101
Idiotype vaccines for lymphoma: proof-of-principles and clinical trial failures
Bendandi, M. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2717 · Cited by 100
Seliger, B., Stoehr, R., Handke, D., Müeller, A., Ferrone, S., Wullich, B., Tannapfel, A., Hofstaedter, F., & Hartmann, A. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0769-5 · Cited by 100
Impact of Tumour Volume on the Potential Efficacy of Therapeutic Vaccines
Gulley, J. L., Madan, R. A., & Schlom, J. (2011) · Current Oncology · doi:10.3747/co.v18i3.783 · Cited by 100
Self-citationBorrello, I., Levitsky, H. I., Stock, W., et al. (2009) · Blood · doi:10.1182/blood-2009-02-205278 · Cited by 98
Natural immunity to pluripotency antigen OCT4 in humans
Dhodapkar, K. M., Feldman, D. R., Matthews, P., Radfar, S., Pickering, R., Turkula, S., Zebroski, H. A., & Dhodapkar, M. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915086107 · Cited by 97
Gilewski, T. A., Ragupathi, G., Dickler, M. N., Powell, S., Bhuta, S., Panageas, K., Koganty, R. R., Chin-Eng, J., Hudis, C. A., Norton, L., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2189 · Cited by 91
Kemp, T. J., García‐Piñeres, A., Falk, R. T., Poncelet, S. M., Dessy, F. J., Giannini, S. L., Rodríguez, A. C., Porras, C., Herrero, R., Hildesheim, A., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.04.074 · Cited by 90
Tatari-Calderone, Z., Semnani, R. T., Nutman, T. B., Schlom, J., & Sabzevari, H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6162 · Cited by 89
Self-citationGelbard, A. H., Garnett‐Benson, C., Abrams, S. I., Patel, V., Gutkind, J. S., Palena, C., Tsang, K.-Y., Schlom, J., & Hodge, J. W. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1761 · Cited by 87
Self-citationDesirable cell death during anticancer chemotherapy
Locher, C., Conforti, R., Aymeric, L., Ma, Y., Yamazaki, T., Rusakiewicz, S., Tesnière, A., Ghiringhelli, F., Apétoh, L., Morel, Y., et al. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05763.x · Cited by 84
Wansley, E. K., Chakraborty, M., Hance, K. W., Bernstein, M. B., Boehm, A. L., Guo, Z., Quick, D. M., Franzusoff, A., Greiner, J. W., Schlom, J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0393 · Cited by 84
Self-citationVaccination-Induced Autoimmune Vitiligo Is a Consequence of Secondary Trauma to the Skin
Lane, C., Leitch, J., Xiaohua, T., Hadjati, J., Bramson, J. L., & Wan, Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3227 · Cited by 82
Xiang, R., Luo, Y., Niethammer, A. G., & Reisfeld, R. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00613.x · Cited by 81
Racanelli, V., Leone, P., Frassanito, M. A., Brunetti, C., Perosa, F., Ferrone, S., & Dammacco, F. (2009) · Blood · doi:10.1182/blood-2009-06-228676 · Cited by 79
Kudo‐Saito, C., Schlom, J., & Hodge, J. W. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1380 · Cited by 78
Self-citationMorris, J. C., Shapiro, G. I., Tan, A. R., Lawrence, D. P., Olencki, T. E., Dezube, B. J., Hsu, F. J., Reiss, M., & Berzofsky, J. A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.9028 · Cited by 78
Gameiro, S. R., Caballero, J. A., Higgins, J. P., Apelian, D., & Hodge, J. W. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1020-8 · Cited by 77
Karbach, J., Neumann, A., Atmaca, A., Wahle, C., Brand, K., von Boehmer, L., Knuth, A. K., Bender, A., Ritter, G., Old, L. J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1811 · Cited by 75
Chakraborty, M., Wansley, E. K., Carrasquillo, J. A., Yu, S. G., Paik, C. H., Camphausen, K. A., Becker, M. D., Goeckeler, W. F., Schlom, J., & Hodge, J. W. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0335 · Cited by 73
Self-citationClinical development of mAbs to block the PD1 pathway as an immunotherapy for cancer.
Kline, J. P., & Gajewski, T. F. (2010) · PubMed · Cited by 71
Gnjatic, S., Wheeler, C., Ebner, M., Ritter, E., Murray, A., Altorki, N. K., Ferrara, C. A., Hepburne-Scott, H., Joyce, S., Koopman, J., et al. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.10.016 · Cited by 71
Respa, A., Bukur, J., Ferrone, S., Pawelec, G., Zhao, Y., Wang, E., Marincola, F. M., & Seliger, B. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2114 · Cited by 71
Zeytin, H. E., Patel, A. C., Rogers, C. J., Canter, D. J., Hursting, S. D., Schlom, J., & Greiner, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3878 · Cited by 67
Self-citationRüter, J., Barnett, B. G., Kryczek, I., Brumlik, M. J., Daniel, B. J., Coukos, G., Zou, W., & Curiel, T. J. (2009) · Frontiers in bioscience · doi:10.2741/3338 · Cited by 66
TGFβ and cancer metastasis: an inflammation link
Yang, L. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9226-3 · Cited by 65
Michel, S., Linnebacher, M., Alcaniz, J., Voss, M., Wagner, R., Dippold, W. G., Becker, C., Doeberitz, M. V. K., Ferrone, S., & Kloor, M. (2009) · International Journal of Cancer · doi:10.1002/ijc.25106 · Cited by 65
Greiner, J. W., Guadagni, F., Goldstein, D., Smalley, R. V., Borden, E. C., Simpson, J. F., Molinolo, A., & Schlom, J. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.5.735 · Cited by 64
Self-citationAndrès, A., Majno, P. E., Morel, P., Rubbia‐Brandt, L., Giostra, E., Gervaz, P., Terraz, S., Allal, A. S., Roth, A. D., & Mentha, G. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9607-1 · Cited by 62
Brichard, V. G., & Lejeune, D. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.7.951 · Cited by 62
Mellstedt, H., Vansteenkiste, J., & Thatcher, N. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.02.023 · Cited by 61
Remondo, C., Cereda, V., Mostböck, S., Sabzevari, H., Franzusoff, A., Schlom, J., & Tsang, K. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.12.002 · Cited by 60
Self-citationMine, T., Matsueda, S., Li, Y., Tokumitsu, H., Gao, H., Danes, C., Wong, K., Wang, X., Ferrone, S., & Ioannides, C. G. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0623-1 · Cited by 60
Pejawar‐Gaddy, S., Rajawat, Y. S., Hilioti, Z., Jia, X., Gaddy, D. F., Finn, O. J., Viscidi, R. P., & Bossis, I. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0895-0 · Cited by 59
Autoantibodies Against Cancer Antigens
Gnjatic, S., Old, L. J., & Chen, Y. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-811-9_2 · Cited by 56
Vergati, M., Cereda, V., Madan, R. A., Gulley, J. L., Huen, N. Y. M., Rogers, C. J., Hance, K. W., Arlen, P. M., Schlom, J., & Tsang, K. Y. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0927-9 · Cited by 53
Self-citationUse of radiolabeled monoclonal antibody to enhance vaccine-mediated antitumor effects
Chakraborty, M., Gelbard, A. H., Carrasquillo, J. A., Yu, S. G., Mamede, M. H., Paik, C. H., Camphausen, K. A., Schlom, J., & Hodge, J. W. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0449-x · Cited by 52
Self-citationPrevention of cancer through immunization: Prospects and challenges for the 21st century
Frazer, I. H., Lowy, D. R., & Schiller, J. T. (2007) · European Journal of Immunology · doi:10.1002/eji.200737820 · Cited by 49
Finn, O. J., Gantt, K. R., Lepisto, A. J., Pejawar‐Gaddy, S., Jia, X., & Beatty, P. L. (2011) · Immunologic Research · doi:10.1007/s12026-011-8214-1 · Cited by 48
Avidity of CD8 T cells sharpens immunodominance
Dzutsev, A. H., Belyakov, I. M., Isakov, D., Margulies, D. H., & Berzofsky, J. A. (2007) · International Immunology · doi:10.1093/intimm/dxm016 · Cited by 41
Kaplan, C. D., Krüger, J. A., Zhou, H., Luo, Y., Xiang, R., & Reisfeld, R. A. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.04.071 · Cited by 41
di Bari, M. G., Lutsiak, M. E. C., Takai, S., Mostböck, S., Farsaci, B., Semnani, R. T., Wakefield, L. M., Schlom, J., & Sabzevari, H. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0692-9 · Cited by 36
Self-citationChakraborty, M., Schlom, J., & Hodge, J. W. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0291-6 · Cited by 33
Self-citationMadan, R. A., Mohebtash, M., Schlom, J., & Gulley, J. L. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903321421 · Cited by 32
Self-citationHodge, J. W., Higgins, J. P., & Schlom, J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.05.017 · Cited by 30
Self-citationLutsiak, M. E. C., Tagaya, Y., Adams, A. J., Schlom, J., & Sabzevari, H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.5871 · Cited by 29
Self-citationCross-Talk between Tumor and Myeloid Cells: How to Tip the Balance in Favor of Antitumor Immunity
Lindenberg, J. J., Fehres, C. M., van Cruijsen, H., Oosterhoff, D., & de Gruijl, T. D. (2010) · Immunotherapy · doi:10.2217/imt.10.95 · Cited by 29
Arredouani, M. S., Tseng-Rogenski, S. S., Hollenbeck, B. K., Escara-Wilke, J. F., Leander, K. R., Defeo-Jones, D., Hwang, C., & Sanda, M. G. (2010) · The Prostate · doi:10.1002/pros.21134 · Cited by 27
The Thymus and the Immune System: Layered Levels of Control
Lee, D. K., Hakim, F. T., & Gress, R. E. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181f20474 · Cited by 26
Vaccines for glioblastoma and high-grade glioma
Wheeler, C. J., & Black, K. L. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.71 · Cited by 26
The Resurrection of T Cell-Mediated Suppression
Shevach, E. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100364 · Cited by 24
Schlom, J., Gulley, J. L., & Hodge, J. W. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm066 · Cited by 20
Self-citationEmerging strategies in regulatory T-cell immunotherapies.
Gajewski, T. F., Chesney, J. A., & Curriel, T. J. (2009) · PubMed · Cited by 20
Morse, M. A., Niedzwiecki, D., Marshall, J., Garrett, C. R., Chang, D. Z., Aklilu, M., Crocenzi, T. S., Cole, D. J., Dessureault, S., Hobeika, A. C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.15_suppl.3557 · Cited by 12
Dhodapkar, M. V., & Dhodapkar, K. M. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0944-8 · Cited by 11
Bogdahn, U., Hau, P., Olyushin, V. E., Mahapatra, A. K., Парфенов, В. Е., Venkataramana, N. K., Wassmann, H., Ludwig, S., Heinrichs, H., & Schlingensiepen, K.-H. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.2018 · Cited by 7
Lyerly, H. K., Hobeika, A. C., Niedzwiecki, D., Osada, T., Marshall, J., Garrett, C. R., Chang, D. Z., Aklilu, M., Crocenzi, T. S., Cole, D. J., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.15_suppl.2533 · Cited by 6
Cited by
Huang, Y., Yuan, J., Righi, E., Kamoun, W. S., Ancukiewicz, M., Nezivar, J., Santosuosso, M., Martin, J. D., Martin, M. R., Vianello, F., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215397109 · Cited by 1,099
The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
Emens, L. A., & Middleton, G. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0064 · Cited by 831
Clinical use of dendritic cells for cancer therapy
Anguille, S., Smits, E. L., Lion, E., van Tendeloo, V. F., & Berneman, Z. N. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70585-0 · Cited by 700
Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy
Huang, Y., Goel, S., Duda, D. G., Fukumura, D., & Jain, R. K. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4354 · Cited by 669
Immunological landscape and immunotherapy of hepatocellular carcinoma
Prieto, J., Melero, I., & Sangro, B. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.173 · Cited by 566
Metadata
- Authors
- Schlom, J.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-03-06
- Volume
- 104
- Issue
- 8
- Pages
- 599-613
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2096825083
- Cited by
- 282
- References
- 194
- FWCI
- 17.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.